Aclaris therapeutics reports first quarter 2021 financial results and provides a corporate update

Wayne, pa., may 07, 2021 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the first quarter of 2021 and provided a corporate update.
ACRS Ratings Summary
ACRS Quant Ranking